Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,617 | -3,096 | 15,623 | -18,470 | N/A |
| Depreciation Amortization | 754 | 660 | 713 | 707 | N/A |
| Accounts receivable | 11,945 | 22,989 | -30,397 | -701 | N/A |
| Accounts payable and accrued liabilities | -405 | -103 | -898 | -1,420 | N/A |
| Other Working Capital | 2,620 | 17,788 | -41,102 | -5,728 | N/A |
| Other Operating Activity | -6,877 | -19,601 | 33,100 | 2,854 | 0 |
| Operating Cash Flow | $3,420 | $18,637 | $-22,961 | $-22,758 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -166 | -1,193 | -221 | -389 | N/A |
| Purchase Of Investment | -113,251 | -90,258 | -78,515 | -26,625 | N/A |
| Sale Of Investment | 126,612 | 62,849 | 48,821 | 50,791 | N/A |
| Investing Cash Flow | $13,195 | $-28,602 | $-29,915 | $23,777 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,700 | 1,500 | N/A | N/A | N/A |
| Debt Repayment | -534 | -672 | -596 | -833 | N/A |
| Common Stock Issued | 1,318 | 117 | 57 | 48 | N/A |
| Common Stock Repurchased | N/A | N/A | -1,100 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 48,675 | 0 |
| Financing Cash Flow | $11,484 | $945 | $-1,639 | $47,890 | $N/A |
| Beginning Cash Position | 12,056 | 21,076 | 75,591 | 26,682 | N/A |
| End Cash Position | 40,155 | 12,056 | 21,076 | 75,591 | N/A |
| Net Cash Flow | $28,099 | $-9,020 | $-54,515 | $48,909 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,420 | 18,637 | -22,961 | -22,758 | N/A |
| Capital Expenditure | -166 | -1,193 | -221 | -389 | N/A |
| Free Cash Flow | 3,254 | 17,444 | -23,182 | -23,147 | 0 |